OpGen, Inc
OPGN
OPGN was delisted on the 19th of August, 2024.
1 hedge funds and large institutions have $6 invested in OpGen, Inc in 2024 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 7 closing their positions.
86% less funds holding
Funds holding: 7 → 1 (-6)
86% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 7
100% less capital invested
Capital invested by funds: $12.3K → $6 (-$12.3K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jones Financial Companies
Des Peres,
Missouri
|
+$8 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TRCT
Tower Research Capital (TRC)
New York
|
-$4.7K |
| 2 |
BlackRock
New York
|
-$4.12K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$3.21K |
| 4 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
-$207 |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$24 |
OPGN Hedge Fund Activity: Q3 2024 in Review
1 of the 6,978 institutional investors tracked by Wall St. Rank reported a position in OpGen, Inc (OPGN) for Q3 2024, worth a combined $6 — down 100% from $12.3K a quarter earlier.
Sellers outnumbered buyers: 7 funds closed out of OPGN and 1 opened new positions — a net loss of 6 holders — while 0 trimmed existing stakes and 0 added.
The largest buyer was Jones Financial Companies, opening a new position worth an estimated $8. The largest seller was Tower Research Capital (TRC), exiting entirely with an estimated $4.7K sold.
- 1 institutional investor held OpGen, Inc (OPGN) as of Q3 2024, down from 7 in Q2 2024.
- Funds reported $6 of OpGen, Inc stock for Q3 2024, down 100% quarter-over-quarter.
- 1 fund opened new OpGen, Inc positions in Q3 2024 and 7 closed out, a net change of -6 holders.
- The largest OpGen, Inc buyer in Q3 2024 was Jones Financial Companies, an estimated $8 added.
- The largest OpGen, Inc seller in Q3 2024 was Tower Research Capital (TRC), an estimated $4.7K sold.
Based on aggregated 13F filings for Q3 2024.